FibroBiologics, Inc.
FibroBiologics, Inc. (FBLG): ~1 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
1.3 months
D/E 1.28
N/A
N/A
N/A
6 buys · 0 sells (180d)
A transparent, data-derived signal for FibroBiologics, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$4.1M
Cash
$1.5M
Quarterly Burn
$4.4M
Runway
1.3 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
13
Total value held
$281K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 135,330 | $179K |
| geode capital management, llc | 29,609 | $39K |
| blackrock, inc. | 24,647 | $33K |
| renaissance technologies llc | 15,997 | $21K |
| vanguard fiduciary trust co | 6,380 | $8K |
| tower research capital llc (trc) | 460 | $607 |
| western wealth management, llc | 200 | $264 |
| islay capital management, llc | 169 | $223 |
| osaic holdings, inc. | 154 | $203 |
| bnp paribas financial markets | 66 | $87 |
Showing top 10 of 13 institutional holders of FibroBiologics, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
What is FibroBiologics, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, FibroBiologics, Inc. has approximately 1.3 months of cash runway.
What is FibroBiologics, Inc.'s market capitalization?
FibroBiologics, Inc.'s market capitalization is approximately $4.1M.
Who is the CEO of FibroBiologics, Inc.?
Mr. Peter O'Heeron is the chief executive officer of FibroBiologics, Inc. (FBLG).
Get the full picture on FibroBiologics, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.